Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Xarelto“
Suchtreffer
Begriffe & Kennungen
Xarelto · 4.3 · Active clinically significant bleeding.
Eintrag öffnenXarelto · 4.3 · Active clinically significant bleeding.
Eintrag öffnenXarelto · 4.3 · Concomitant treatment of ACS with antiplatelet therapy in patients with a prior stroke or a transient ischaemi
Eintrag öffnenXarelto · 4.3 · Concomitant treatment of CAD/PAD with ASA in patients with previous haemorrhagic or lacunar stroke, or any str
Eintrag öffnenXarelto · 4.3 · Concomitant treatment with any other anticoagulants, e.g. unfractionated heparin (UFH), low molecular weight h
Eintrag öffnenXarelto · 4.3 · Concomitant treatment with any other anticoagulants, e.g. unfractionated heparin (UFH), low molecular weight h
Eintrag öffnenXarelto · 4.3 · Concomitant treatment with any other anticoagulants, e.g. unfractionated heparin (UFH), low molecular weight h
Eintrag öffnenXarelto · 4.3 · Concomitant treatment with any other anticoagulants, e.g. unfractionated heparin (UFH), low molecular weight h
Eintrag öffnenXarelto · 4.3 · Concomitant treatment with any other anticoagulants, e.g. unfractionated heparin (UFH), low molecular weight h
Eintrag öffnenXarelto · 4.3 · Concomitant treatment with any other anticoagulants, e.g. unfractionated heparin (UFH), low molecular weight h
Eintrag öffnenXarelto · 4.3 · Hepatic disease associated with coagulopathy and clinically relevant bleeding risk including cirrhotic patient
Eintrag öffnenXarelto · 4.3 · Hepatic disease associated with coagulopathy and clinically relevant bleeding risk including cirrhotic patient
Eintrag öffnenXarelto · 4.3 · Hepatic disease associated with coagulopathy and clinically relevant bleeding risk including cirrhotic patient
Eintrag öffnenXarelto · 4.3 · Hepatic disease associated with coagulopathy and clinically relevant bleeding risk including cirrhotic patient
Eintrag öffnenXarelto · 4.3 · Hepatic disease associated with coagulopathy and clinically relevant bleeding risk including cirrhotic patient
Eintrag öffnenXarelto · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenXarelto · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenXarelto · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenXarelto · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenXarelto · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnen